Historical record - last NADAC effective date: 11/23/2016
Product Information
ATRALIN 0.05% GEL is a brand product labeled by Bausch Health US LLC, priced at $11.9379 per GM under NDC 13548007045. Its NADAC has been published 203 times since Nov 28, 2013.
FDA first approved this application on Jul 26, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.05 g/100g
Manufacturer
Bausch Health US LLCNDC
13548007045
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
11/23/2016
Active Ingredients
TRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA022070FDA Approved
7/26/2007
TE Code
AB
On Market Since
7/26/2007
Pharmacological Classes
Price Statistics
The NADAC for ATRALIN 0.05% GEL has been published 203 times since Nov 28, 2013, and over the history we have for it it has risen 83.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.9379 per GM |
|---|---|
| All-time high | $12.0243 (Sep 14, 2016) |
| All-time low | $6.4943 (Nov 28, 2013) |
| Median price | $11.9379 |
| Average price | $10.0673 |
| Largest weekly change | +40.0% (Sep 9, 2015) |
| Weeks tracked | 203 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+83.8%
Last surveyed Dec 13, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATRALIN 0.05% GEL?
The current National Average Drug Acquisition Cost (NADAC) for ATRALIN 0.05% GEL, manufactured by Bausch Health US LLC, is $11.9379 per GM (NDC 13548007045), effective Dec 13, 2017.
How has the price of ATRALIN 0.05% GEL changed over time?
Over the history we have for it, the NADAC for ATRALIN 0.05% GEL has risen 83.8%. It has been tracked across 203 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ATRALIN 0.05% GEL?
Since Nov 28, 2013, the NADAC for ATRALIN 0.05% GEL has ranged from a low of $6.4943 (Nov 28, 2013) to a high of $12.0243 (Sep 14, 2016), with a median of $11.9379 per GM.
Are there cheaper alternatives to ATRALIN 0.05% GEL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRETINOIN 0.05% GEL, is $4.1874 per GM — about 65% below ATRALIN 0.05% GEL.
Who manufactures ATRALIN 0.05% GEL?
ATRALIN 0.05% GEL (NDC 13548007045) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.